Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
Cives, M, Ghayouri, M, Morse, B, Brelsford, M, Black, M, Rizzo, A, Meeker, A, Strosberg, J
Published in Endocrine-related cancer (01.09.2016)
Published in Endocrine-related cancer (01.09.2016)
Get full text
Journal Article
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
Öberg, K., Califano, A., Strosberg, J.R., Ma, S., Pape, U., Bodei, L., Kaltsas, G., Toumpanakis, C., Goldenring, J.R., Frilling, A., Paulson, S.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Analysis of the immune landscape of small bowel neuroendocrine tumors
Cives, M, Strosberg, J, Al Diffalha, S, Coppola, D
Published in Endocrine-related cancer (01.01.2019)
Published in Endocrine-related cancer (01.01.2019)
Get full text
Journal Article
Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
Al-Toubah, T., Halfdanarson, T., Gile, J., Morse, B., Sommerer, K., Strosberg, J.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
O-20 Phase I/IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Kim, R., Imanirad, I., Carballido, E., Strosberg, J., Kim, Y., Kim, D.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)
Chan, J., Geyer, S., Ou, F-S., Knopp, M., Behr, S., Zemla, T., Acoba, J., Shergill, A., Wolin, E.M., Halfdanarson, T.R., Trikalinos, N., Konda, B., Vijayvergia, N., Dasari, N.A., Strosberg, J., Kohn, E.C., Kulke, M.H., O'Reilly, E.M., Meyerhardt, J.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
Cives, M, Kunz, P L, Morse, B, Coppola, D, Schell, M J, Campos, T, Nguyen, P T, Nandoskar, P, Khandelwal, V, Strosberg, J R
Published in Endocrine-related cancer (01.02.2015)
Published in Endocrine-related cancer (01.02.2015)
Get full text
Journal Article
A phase II study of axitinib in advanced neuroendocrine tumors
Strosberg, J R, Cives, M, Hwang, J, Weber, T, Nickerson, M, Atreya, C E, Venook, A, Kelley, R K, Valone, T, Morse, B, Coppola, D, Bergsland, E K
Published in Endocrine-related cancer (01.05.2016)
Published in Endocrine-related cancer (01.05.2016)
Get full text
Journal Article
Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
Al-Toubah, T., Schell, M.J., Morse, B., Haider, M., Valone, T., Strosberg, J.
Published in ESMO open (01.04.2024)
Published in ESMO open (01.04.2024)
Get full text
Journal Article
Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
Yao, J.C., Strosberg, J., Fazio, N., Pavel, M.E., Ruszniewski, P., Bergsland, E., Li, D., Tafuto, S., Raj, N., Campana, D., Hijioka, S., Raderer, M., Guimbaud, R., Gajate, P., Pusceddu, S., Reising, A., Degtyarev, E., Mookerjee, B., Aimone, P., Singh, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients
Dumont, A.G., Rink, L., Godwin, A.K., Miettinen, M., Joensuu, H., Strosberg, J.R., Gronchi, A., Corless, C.L., Goldstein, D., Rubin, B.P., Maki, R.G., Lazar, A.J., Lev, D., Trent, J.C., von Mehren, M.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET)
Segelov, E., Bergsland, E., Card, C., Hope, T., Kunz, P., Laidley, D., Lawrence, B., Leyden, S., Michael, M., Modahl, L., Myrehaug, S., Padda, S., Pommier, R., Ramirez, R., Soulen, M., Strosberg, J., Thawer, A., Wei, B., Singh, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study
Strosberg, J., Hendifar, A., Yao, J.C., Kulke, M., O’Dorisio, T., Caplin, M., Baum, R.P., Kunz, P., Hobday, T., Wolin, E., Mittra, E.S., Oberg, K., Ruszniewski, P., Polack, B., He, B., Barton, D., Santaro, P., Krenning, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors
Strosberg, J R, Chan, J A, Ryan, D P, Meyerhardt, J A, Fuchs, C S, Abrams, T, Regan, E, Brady, R, Weber, J, Campos, T, Kvols, L K, Kulke, M H
Published in Endocrine-related cancer (01.06.2013)
Published in Endocrine-related cancer (01.06.2013)
Get full text
Journal Article
Pancreatic NETs: where do we stand now?
Faivre, S., Castellano, D., Strosberg, J., González, E., Salazar, R.
Published in Cancer and metastasis reviews (01.03.2014)
Published in Cancer and metastasis reviews (01.03.2014)
Get full text
Journal Article
SP-0570: Neuroendocrine tumours - personalised diagnosis and treatment using radiolabelled peptides
Baum, R.P, Strosberg, J, Wolin, E, Chasen, B, Kulke, M, Bushnell, D, Caplin, M, Hobday, T, Hendifar, A, Oberg, K, Lopera Sierra, M, Kwekkeboom, D, Ruszniewsk, P, Krenning, E, Mittra, E
Published in Radiotherapy and oncology (01.04.2016)
Published in Radiotherapy and oncology (01.04.2016)
Get full text
Journal Article
6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial
Strosberg, J, Wolin, E, Chasen, B, Kulke, M, Bushnell, D, Caplin, M, Baum, R.P, Mittra, E, Hobday, T, Hendifar, A, Oberg, K, Lopera Sierra, M, Ruszniewski, P, Kwekkeboom, D
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study
Yao, J, Fazio, N, Singh, S, Buzzoni, R, Carnaghi, C, Wolin, E, Tomasek, J, Raderer, M, Lahner, H, Voi, M, Pacaud, L, Lincy, J, Sachs, C, Valle, J, Delle Fave, G, Van Cutsem, E, Tesselaar, M.E.T, Shimada, Y, Oh, D.Y, Strosberg, J, Kulke, M.H, Pavel, M.E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma
Srikumar, T, Markow, M, Centeno, B, Hoffe, S, Tao, J, Fernandez, H, Strosberg, J, Shibata, D
Published in Current oncology (Toronto) (01.02.2016)
Published in Current oncology (Toronto) (01.02.2016)
Get full text
Journal Article